ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Directory Of NCI Numbers Available

March 22, 1985

In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants

June 24, 1983

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

In Brief: Search Committee Could Finish Job Weeks, Perry Says Nominations Are Being Solicited

January 11, 1980

DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial

October 13, 1995